ascorbic acid / hyaluronate
- RxCUI
- 1008091
- RxNorm name
- ascorbic acid / hyaluronate
- Term type
- MIN
- Status
- Active
- Updated
- 2026-06-18 07:02:27
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- YES
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| ascorbic acid | 1151 |
| hyaluronate | 62372 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | ascorbic acid / hyaluronate | NAMES |
| RxNorm Name | ascorbic acid / hyaluronate | NAMES |
| TTY | MIN | ATTRIBUTES |
| RxCUI | 1008091 | CODES |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A11GA | Ascorbic acid (vitamin C), plain | ATC1-4 | ascorbic acid | |
| ATC | G01AD | Organic acids | ATC1-4 | ascorbic acid | |
| ATC | D03AX | Other cicatrizants | ATC1-4 | hyaluronic acid | |
| ATC | M09AX | Other drugs for disorders of the musculo-skeletal system | ATC1-4 | hyaluronic acid | |
| ATC | R01AX | Other nasal preparations | ATC1-4 | hyaluronic acid | |
| ATC | S01XA | Other ophthalmologicals | ATC1-4 | ascorbic acid | |
| ATC | S01KA | Viscoelastic substances | ATC1-4 | hyaluronic acid | |
| FDASPL | D001205 | Ascorbic Acid | CHEM | has_chemical_structure | ascorbic acid |
| FDASPL | N0000193618 | Vitamin C | EPC | has_epc | ascorbic acid |
| MEDRT | D001205 | Ascorbic Acid | CHEM | has_ingredient | ascorbic acid |
| MEDRT | D006820 | Hyaluronic Acid | CHEM | has_ingredient | hyaluronic acid |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | ascorbic acid |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | hyaluronate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | hyaluronic acid |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | ascorbic acid |
| MEDRT | D006959 | Hyperoxaluria | DISEASE | induces | ascorbic acid |
| MEDRT | D008708 | Methemoglobinemia | DISEASE | may_treat | ascorbic acid |
| MEDRT | D010146 | Pain | DISEASE | may_treat | hyaluronic acid |
| MEDRT | D012614 | Scurvy | DISEASE | may_treat | ascorbic acid |
| MEDRT | D012883 | Skin Ulcer | DISEASE | may_treat | hyaluronate |
| MEDRT | D012883 | Skin Ulcer | DISEASE | may_treat | hyaluronic acid |
| MEDRT | D020176 | Tyrosinemias | DISEASE | may_treat | ascorbic acid |
| MEDRT | D014947 | Wounds and Injuries | DISEASE | may_treat | hyaluronic acid |
| MEDRT | D014947 | Wounds and Injuries | DISEASE | may_treat | hyaluronate |
| MEDRT | D014950 | Wounds, Penetrating | DISEASE | may_treat | ascorbic acid |
| MEDRT | N0000000142 | Biological Macromolecular Activity | MOA | has_moa | hyaluronic acid |
| MEDRT | N0000000163 | Enzyme Interactions | MOA | has_moa | ascorbic acid |
| MEDRT | N0000000170 | Free Radical Scavenging Activity | MOA | has_moa | ascorbic acid |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | ascorbic acid |
| MEDRT | N0000008373 | Connective Tissue Alteration | PE | has_pe | hyaluronic acid |
| MEDRT | N0000009057 | Generalized Systemic Effects | PE | has_pe | hyaluronic acid |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | TTY | MIN |
| CODES | RxCUI | 1008091 |
| NAMES | RXNAV_STR | ascorbic acid / hyaluronate |
| NAMES | RxNorm Name | ascorbic acid / hyaluronate |